Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pharmacyclics
Pharmacyclics
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
MannKind
Alkermes
Gilead Sciences
ledipasvir
AbbVie
Afrezza
aripiprazole lauroxil
Pharmacyclics
Imbruvica
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
AbbVie
Amgen
Gilead Sciences
Achillion
Alexion
Ariad Pharmaceuticals
Pharmacyclics
Seattle Genetics
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thu, 03/20/14 - 05:26 pm
Imbruvica
Pharmacyclics
Gilead Sciences
Biogen Idec
chronic lymphocytic leukemia
J&J, Pharmacyclics drug gets U.S. approval for leukemia
Yahoo/Reuters
Wed, 02/12/14 - 06:46 pm
FDA
JNJ
Pharmacyclics
Imbruvica
chronic lymphocytic leukemia
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
M&A
biotech
generics
Merck
Bristol-Myers Squibb
General Electric
Gilead Sciences
Thermo Fisher
Forest Labs
FDA
Acorda Therapeutics
Pfizer
JNJ
Roche
Pharmacyclics
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Yahoo/Investors Business Daily
Wed, 01/8/14 - 08:05 am
Valeant Pharmaceuticals
Pharmacyclics
Imbruvica
Celgene
EPZ-5676
Epizyme
Pharmacyclics Shares Rise on Positive Leukemia Trial
Bloomberg
Tue, 01/7/14 - 11:49 am
Pharmacyclics
JNJ
Imbruvica
chronic lymphocytic leukemia
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Pharmacyclics
Imbruvica
JNJ
Roche
Celgene
Gilead Sciences
mantle cell lymphoma
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Ziopharm
cancer
AbbVie
Amgen
Celgene
Celldex Therapeutics
Gilead Sciences
Immunogen
JNJ
ImmunoCellular Therapeutics
Pharmacyclics
Intrexon
Seattle Genetics
Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013
Motley Fool
Sat, 12/14/13 - 12:03 pm
Celgene Corporation
Pharmacyclics
mantle cell lymphoma
JNJ
Imbruvica
Revlimid
Is CytRx Corporation the Next Pharmacyclics?
Wall St Cheat Sheet
Fri, 12/13/13 - 04:47 pm
CytRx
Pharmacyclics
doxorubicin
New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Gilead Sciences
Roche
Pharmacyclics
CLL
chronic lymphocytic leukemia
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
chronic lymphocytic leukemia
Gilead
Pharmacyclics
CLL
Roche
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Four Biotech 'Surprise' Stocks for 2014
TheStreet.com
Wed, 11/27/13 - 08:34 am
Seattle Genetics
Adcetris
Cubist Pharmaceuticals
Cempra
Eylea
Regeneron
Pharmacyclics
Imbruvica
Gilead
sofosbuvir
Johnson & Johnson’s Imbruvica Will Be a Costly Treatment
Wall St Cheat Sheet
Mon, 11/18/13 - 04:36 pm
JNJ
Imbruvica
mantle cell lymphoma
Pharmacyclics
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Vanda
Cadence Pharmaceuticals
Immunogen
Novartis
Pharmacyclics
JNJ
Epizyme
Sarepta Therapeutics
GSK
Why Aren't Investors More Excited About Pharmacyclics' FDA Approval?
Motley Fool
Sat, 11/16/13 - 01:15 pm
Pharmacyclics
Imbruvica
mantle cell lymphoma
Pharmacyclics' Lymphoma Drug Receives FDA Approval
TheStreet.com
Wed, 11/13/13 - 12:50 pm
Pharmacyclics
FDA
Imbruvica
mantle cell lymphoma
ibrutinib
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »